Dr. Melmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5020 E Shea Blvd
Ste 100
Scottsdale, AZ 85254Phone+1 480-443-0050
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1979 - 1981- Boston Children’s Hospital/Boston Medical Center AFellowship, Developmental-Behavioral Pediatrics, 1981
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Pediatrics, 1977 - 1979
University of Cape Town Faculty of MedicineClass of 1974
Certifications & Licensure
AZ State Medical License 1982 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Developmental-Behavioral Pediatrics
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
- Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
- Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTwo single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD.Caitlin A Stamatis, Deborah N Farlow, Catherine Mercaldi, Minny Suh, Amanda Maple
Npj Mental Health Research. 2024-06-19 - 30 citationsEvaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorder.Jonathan T Megerian, Sangeeta Dey, Raun D Melmed, Daniel L Coury, Marc Lerner
NPJ Digital Medicine. 2022-05-05 - 5 citationsThe STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.Lynne M. Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, Gali Heimer, Raun D. Melmed
Neurology. 2020-12-21
Press Mentions
FDA Approves Prescription-Only Video Game for Children with ADHDJune 17th, 2020
Akili Announces ENDEAVORTM Digital Attention Treatment Is Now Available for Children with Attention Deficit Hyperactivity Disorder (ADHD) Under FDA’s COVID-19 Enforcement Discretion GuidanceApril 22nd, 2020
Traveling with an Autistic Child: Tips to Make Your Trip EasierJanuary 15th, 2020- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
